Journal
CLINICAL GENETICS
Volume -, Issue -, Pages -Publisher
WILEY
DOI: 10.1111/cge.14404
Keywords
clinical management; congenital heart defects; CTNNB1; neurodevelopmental disorder; Wnt-& beta;-catenin signaling
Categories
Ask authors/readers for more resources
Variants in the CTNNB1 gene are associated with neurodevelopmental disorder, visual defects, and congenital heart anomalies. A study on 19 NEDSDV patients found that 5 of them had congenital heart defects, highlighting the importance of cardiac examination in NEDSDV clinical management.
CTNNB1 [OMIM *116806] encodes beta-catenin, an integral part of the cadherin/catenin complex, which functions as effector of Wnt signaling. CTNNB1 is highly expressed in brain as well as in other tissues, including heart. Heterozygous CTNNB1 pathogenic variations are associated with a neurodevelopmental disorder characterized by spastic diplegia and visual defects (NEDSDV) [OMIM #615075], featuring psychomotor delay, intellectual disability, behavioral disturbances, movement disorders, visual defects and subtle facial and somatic features. We report on a new series of 19 NEDSDV patients (mean age 10.3 years), nine of whom bearing novel CTNNB1 variants. Notably, five patients showed congenital heart anomalies including absent pulmonary valve with intact ventricular septum, atrioventricular canal with hypoplastic aortic arch, tetralogy of Fallot, and mitral valve prolapse. We focused on the cardiac phenotype characterizing such cases and reviewed the congenital heart defects in previously reported NEDSDV patients. While congenital heart defects had occasionally been reported so far, the present findings configure a higher rate of cardiac anomalies, suggesting dedicated heart examination to NEDSDV clinical management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available